A compound called D-mannoheptulose blocks glucose breakdown depending on how much gets inside cells, and it acts differently in pancreas versus salivary gland cells.
See the scientific wording
The ability of D-mannoheptulose to inhibit D-glucose metabolism depends on the intracellular transport and availability of D-mannoheptulose within cells, as suggested by its differential effects on pancreatic islets versus parotid cells.
Supported
Observational4 of 4 parts have evidence behind them.
Supported
4 of 4 parts have evidence behind them.
Parts of this claim
D-mannoheptulose inhibits D-glucose metabolism.
Supported1 studyD-mannoheptulose's inhibition of D-glucose metabolism depends on intracellular transport of D-mannoheptulose.
Supported1 studyD-mannoheptulose's inhibition of D-glucose metabolism depends on availability of D-mannoheptulose within cells.
Supported1 studyD-mannoheptulose has differential effects on pancreatic islets versus parotid cells.
Supported1 study
Evidence is judged against each part on its own, so a study that tests one part never counts as a verdict on the whole claim.
What the research says
1 study reviewedSupporting (1)
Cross-Sectional StudyIn vitro1998
The study observed that D-mannoheptulose inhibited phosphorylation in homogenates from both tissues but only suppressed intact islet responses. The authors propose that intracellular transport and availability of the heptose explain this discrepancy, supporting the claim that these factors determine its action.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
A molecule called D-mannoheptulose blocks the first step of sugar burning inside cells. To do this, it must get inside the cell and reach the enzyme that starts sugar burning. Pancreas cells let it in, so they stop burning sugar and stop releasing insulin. Salivary gland cells keep it out, so even though the molecule can block the enzyme in a test tube, it cannot block sugar burning in living salivary gland cells. This shows that how much of the molecule gets inside a cell decides whether it can work.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
A compound called D-mannoheptulose blocks glucose breakdown depending on how much gets inside cells, and it acts differently in pancreas versus salivary gland cells.
Mechanism
1 studyA molecule called D-mannoheptulose can block sugar burning, but only if it gets inside the cell. Pancreas cells let it in, so sugar burning stops and insulin release drops. Salivary gland cells keep it out, so sugar burning continues even though the molecule can block the enzyme outside a living cell. This difference shows that cell entry controls whether the molecule works.
A molecule called D-mannoheptulose blocks the first step of sugar burning inside cells. To do this, it must get inside the cell and reach the enzyme that starts sugar burning. Pancreas cells let it in, so they stop burning sugar and stop releasing insulin. Salivary gland cells keep it out, so even though the molecule can block the enzyme in a test tube, it cannot block sugar burning in living salivary gland cells. This shows that how much of the molecule gets inside a cell decides whether it can work.
D-mannoheptulose crosses the cell membrane and enters the cytoplasm; the amount that enters and remains available inside the cell varies by cell type.
In pancreatic islet B-cells, intracellular D-mannoheptulose reaches hexokinase/glucokinase and binds to the enzyme, blocking the phosphorylation of D-glucose.
Blocked phosphorylation lowers glucose-6-phosphate production, reducing glycolysis and oxidative metabolism of D-glucose.
In pancreatic islet B-cells, reduced D-glucose metabolism decreases the metabolic signal that drives glucose-stimulated insulin release, so insulin secretion falls.
In parotid cells, although hexokinase/glucokinase is susceptible to D-mannoheptulose in cell homogenates, intact cells restrict the intracellular transport and availability of the heptose, so it does not reach the enzyme in sufficient amounts and D-glucose catabolism remains unaffected.
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of In Vitro and Animal Studies on D-Mannoheptulose Transport-Dependent Inhibition of D-Glucose Metabolism
Systematic search and meta-analysis of controlled in vitro studies using pancreatic islet and parotid cells, with D-mannoheptulose applied at varying extracellular concentrations and with transport inhibitors or transporter knockdown, measuring D-glucose metabolism (e.g., glucose oxidation, insulin release) as the outcome.
Randomized Controlled Trial of D-Mannoheptulose Effects on Glucose Metabolism in Humans
Double-blind, placebo-controlled RCT in healthy adults or patients with impaired glucose metabolism, randomized to D-mannoheptulose or placebo, with measures of glucose metabolism (e.g., glucose tolerance, insulin secretion) and, if feasible, tissue-specific transport markers, over acute to short-term duration.
Mechanistic In Vitro Study of D-Mannoheptulose Transport and Inhibition in Pancreatic Islets vs Parotid Cells
Controlled in vitro study using isolated pancreatic islets and parotid cells, with D-mannoheptulose applied at matched extracellular concentrations, with and without transport inhibitors or transporter knockdown/overexpression, measuring intracellular D-mannoheptulose levels and D-glucose metabolism (e.g., glucose oxidation, insulin secretion) over acute incubations.